Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome
Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company dedicated to developing transformative genetic medicines for patients suffering from rare neurological…
AGC Biologics Launches New Cell & Gene Technology Division
AGC Biologics Launches New Cell & Gene Technology Division AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the launch of its new Cell and Gene Technology…
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc.
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc. Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing solutions, has announced a strategic partnership with Tokyo-based SCRUM Inc.…
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) have officially announced the U.S. launch of BORUZU™,…
RenovoRx Announces First RenovoCath Revenues & Phase III Trial Update
RenovoRx Announces First RenovoCath Revenues & Phase III Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a leading life sciences company focused on developing innovative targeted oncology therapies, has announced its financial…
AustinPx Introduces KinetiSol Equipment Leasing Program
AustinPx Introduces KinetiSol™ Equipment Leasing Program AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally administered small molecule drugs, has announced the launch of…
Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials
Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials Unlearn®, a leader in AI-powered solutions for clinical trials, has announced a strategic collaboration with Trace Neuroscience, a biotechnology company…
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion Gameday Men’s Health, a leading men’s health clinic dedicated to redefining wellness through cutting-edge treatments and personalized…
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Europe to Slow Pediatric Myopia Progression
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Europe to Slow Pediatric Myopia Progression Sydnexis, Inc. a pre-commercial stage biopharmaceutical company specializing in ophthalmic therapeutics, has announced a significant regulatory…
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers The antibody-drug conjugate (ADC) market is poised for significant growth, with projections indicating an increase from USD 7.72…
Align Technology Launches Invisalign® With Mandibular Advancement for Class II Correction
Align Technology Launches Invisalign® With Mandibular Advancement for Class II Correction Align Technology, Inc. (Nasdaq: ALGN), a globally recognized medical device company specializing in digital orthodontics and restorative dentistry, has…
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness MANSCAPED, the global leader in men’s grooming, has built a reputation not only for its innovative grooming products and clever…